Melt Pharmaceuticals Inc. PFD Ser B
13F holders, Q2 2025 (June 30)1holders
$0.00avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Melt Pharmaceuticals Inc. PFD Ser B in their 13F filings. The largest holder was Gleason Group, Inc. ($0).
- Company
- Melt Pharmaceuticals Inc. PFD Ser B
- CUSIP
- 584995716
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Gleason Group, Inc. | 0.00% | New | 11,760 | $0 |
"% of holder's portfolio" is MELT PHARMACEUTICALS INC PFD SER B's weight in each manager's 13F, not the share of Melt Pharmaceuticals Inc. PFD Ser B the manager owns.